Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Allarity Therapeutics Inc
ALLRCurrent price
2.3 USD
-0.66 USD (-22.30%)
Last closed
2.99 USD
Company
www.allarity.com
ISIN
US0167441049
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
4 817 136 USD
Yield for 12 month
-99.53 %
1Y
3Y
5Y
10Y
15Y
ALLR
Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. Allarity Therapeutics, Inc. has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. The company was incorporated in 2004 and is headquartered in Boston, Massachusetts. Address: 24 School Street, Boston, MA, United States, 02108
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
+112 000 USD
Current Year
-37 000 USD
Last Year
-120 000 USD
Current Quarter
-1 000 USD
Last Quarter
-2 000 USD
Key Figures ALLR
1 year
3 years
5 years
10 years
EBITDA
-16 895 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-47.72 %
PEG Ratio
–
Return On Equity TTM
-121.82 %
Wall Street Target Price
5 USD
Revenue TTM
-7 127 000 USD
Book Value
16.98 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
-36 348 000 USD
Earnings per share
-10.98 USD
Diluted Eps TTM
-10.98 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALLR
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ALLR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:30
Payout Ratio
–
Last Split Date
11.09.2024
Dividend Date
–
Stock Valuation ALLR
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.0842
Price Book MRQ
0.2429
Financials ALLR
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALLR
For 52 weeks
2.58 USD
539.43 USD
50 Day MA
5.1 USD
Shares Short Prior Month
299 259
200 Day MA
128.03 USD
Short Ratio
0.26
Shares Short
577 150
Short Percent
1.36 %
BeatStart